Coronavirus Disease 2019 (COVID-19) Updates Related to Sponsored Programs

Check here for updates regarding how COVID-19 is affecting sponsored programs at UWM. If you have any information to share, please e-mail us at grant-notice@uwm.edu.

Resources

Title Description
American Heart Association (AHA) Notice to AHA Research Community Regarding COVID-19
BBRF Deadline Extension The Brain & Behavior Research Foundation is extending the deadline for the 2020 BBRF Young Investigator Grant to March 31, 2020.
CDC Interim Guidance for IHE Administrators This interim guidance from the U.S. Centers for Disease Control and Prevention, intended for institutions of higher education, is based on what is currently known about the transmission and severity of coronavirus disease 2019 (COVID-19).
DHHS Administration for Children and Families (ACF) ACF grant flexibilities in conducting human service activities related to or affected by COVID-19.
DHHS (Department of Health and Human Services) (PDF) DHHS Preparation for Potential COVID-19 Impact on Contract and Contractor Performance
DOD Air Force (PDF) Air Force Guidance for No Cost Extensions related to OMB M-20-17 (March 27)
DOD (Department of Defense) Research Directorate FAQs for DOD Research Proposers and Awardees Impacted by the Novel Coronavirus (March 24)
DOE National Lab Updates Guidance related to risks of COVID-19 spread from Battelle (PDF). Similar communication from Brookhaven National Lab (PDF).
DOE Office of Science (PDF) Guidance on travel (PDF) and accommodating interruptions from Coronavirus Disease 2019 (COVID-19).
DOE Seeking Input and Collaboration on S&T Response to COVID-19 (PDF) DOE is seeking ideas about how DOE and the National Labs might contribute resources to help address COVID-19 through science and technology efforts and collaborations.
DOJ COPS Office The DOJ Office of Community Oriented Policing Services has extended the solicitation deadline for several open grant programs due to the potential impact of jurisdictional emergency responses to COVID-19 that may cause reasonable delays for applicants. For detailed individual program information, see the grants page.
DOJ Implementation of OMB Memorandum M-20-17 (PDF) Department of Justice’s implementation of OMB Memorandum M-20-17 “Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations” dated March 19, 2020.
DOJ OJP Update (PDF) An update for grantees from the Office of Justice Programs at the Department of Justice.
Food and Drug Administration (FDA) Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 (March 27).
Health Resources & Services Administration (HRSA) FAQs for Grantees
Institutional and Agency Responses to COVID-19 and Additional Resources A collection of resources from various institutions of higher education compiled by the Council On Governmental Relations.
Institute of Museum and Library Services (IMLS) New Application Deadline Changes and other updates.
John Templeton Foundation A Message to Our Grantees on COVID-19 (March 23)
Mellon Foundation Message The Mellon Foundation’s communication regarding work interruptions due to COVID-19.
NASA Coronavirus Information Updates and resources regarding COVID-19 from NASA.
NASA Update for Researchers NASA Update for Research Virtual Town Hall 2020 (March 23)
NEA FAQs National Endowment for the Arts FAQs for Applicants & Awardees in Response to COVID-19
NEH (National Endowment for the Humanities) FAQs related to NEH funding under the Coronavirus Aid, Relief, and Economic Security (CARES) Act and the OMB Memo M-20-17.
NIH COVID-19 FAQs NIH FAQs on Proposal Submission and Award Management Related to COVID-19 (Issued March 10)
NIH Extramural Nexus Special COVID-19 Edition of the NIH Extramural Nexus. Click here to subscribe to the newsletter, which provides regular updates on NIH grants policies and activities that impact the entire grants community. In addition to providing the community with news, events and resources, the Nexus is the home of Open Mike — the blog of Dr. Michael Lauer, who serves as NIH’s Deputy Director for Extramural Research and directs the Office of Extramural Research.
NIH Guide Notice 20-086 Flexibilities available to applicants and recipients of federal financial assistance affected by COVID-19.
NIH COVID-19 Resource Page NIH information including NIH guidance on travel and meetings.
NIH Extramural Response to Natural Disasters and Other Emergencies NIH policies on natural disasters and other emergencies.
NIH Late Application Policy Due to COVID-19 (March 9) NIH special provisions implemented in response to COVID-19. (Issued March 9)
NIH Notice of Early Expiration of NOSI NOT-A1-20-030 Notice of Early Expiration of NOSI NOT-AI-20-030 Regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (March 27).
NIH Update; Late Application Policy Due to COVID-10 NIH Late Application Policy due to Public Health Emergency for US for COVID-19 (March 26)
NSF COVID-19 FAQs Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees.
NSF Dear Colleague Letter NSF’s Dear Colleague Letter with information regarding the RAPID funding mechanism as it relates to COVID-19.
NSF Implementation of OMB Memorandum M-20-17 (PDF) NSF’s implementation of OMB Memorandum M-20-17 “Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations” dated March 19, 2020.
NSF Statement on Coronavirus Disease 2019 (COVID-19) (PDF) NSF actions in response to COVID-19. (Issued March 9)
NSF Statement on Existing Deadline Dates (PDF) National Science Foundation (NSF) Notice, March 18, 2020. Proposers are advised that NSF is extending the deadline date for certain solicitations or Dear Colleague Letters (DCLs). Additional solicitations or DCLs may be added to the list, so proposers are strongly encouraged to check NSF’s website regularly.
OLAW Disaster Planning and Response Resources The Office of Laboratory Animal Welfare (OLAW) maintains a list of resources and has a list of FAQs, click on G9 to read about how to prepare for a pandemic.
PCORI Guidance Related to Impact of COVID-19 Description: PCORI recognizes that management of COVID-19 is a rapidly evolving and dynamic situation that may impact PCORI-funded awards. If you are encountering institutional or personal challenges or have other concerns related to your PCORI award, please reach out as soon as possible to your PCORI project team: Program Officer, Program Associate, and Contract Administrator. You may also reach us at fundedpfa@pcori.org.
SAMHSA COVID-19 Information for Substance Abuse and Mental Health Services Administration (SAMHSA) Discretionary Grant Recipients
Space Telescope Science Institute (PDF) COVID-19 Impact on the James Webb Space Telescope Cycle 1 GO Proposal Deadline
Spencer Foundation Update from the Spencer Foundation on COVID-19
USDA (United States Department of Agriculture) NIFA Deadline Extensions Due to COVID-19
UWM COVID-19 Updates Up-to-date information from the University of Wisconsin-Milwaukee.
UWM Research Laboratories and Facilities and the COVID-19 Pandemic (March 18, 2020 (PDF) Guidance for working and meeting remotely and developing contingency plans for research and laboratory operations.
USAID Memorandum Authorizing COVID 19 Flexibilities Pursuant to OMB Memo M-20-17 (March 30)
USAMRAA (PDF) Notice from the U.S. Army Medical Research Acquisition and CDMRP for applicants and awardees in response to COVID-19.
WHO COVID-19 information Information and guidance from the World Health Organization regarding the current outbreak of Coronavirus Disease (COVID-19).
WI DNR Surface Water Grants Program (PDF) Surface Water Grants COVID-19 Update (March 30)

UW System: Travel Reimbursement Due to COVID-19 (Issued March 11)

With Chancellor Mone’s recent guidance regarding travel, the following clarifies UW System policies and procedures regarding cancelled airline tickets and reimbursement due to COVID-19.

  • UW System will not be returning any expense reports that have change fees tickets due to Coronavirus.
  • Tickets cancelled due to Coronavirus are a reimbursable expense.
  • Airline Tickets can be cancelled in Concur or by contacting an agent. Typically, tickets stay clarity regarding cancelled airline tickets and reimbursement due to the Coronavirus in the ticket holder’s Concur profile for up to a year. However, due to the upcoming change in travel agencies in July, we are working with our new agency on how travelers can access unused tickets after July 1. Best practice right now is to screenshot and save record of your unused ticket for verification purposes going forward.
  • If a basic economy ticket was booked, no ticket value can be saved and the entire value of the ticket is lost. While cancelled tickets reimbursable if cancelled due to Coronavirus – no unused tickets will be in the traveler’s profile for future use.
  • Review hotel cancellation policies and cancel any hotel reservations ASAP.
  • Questions regarding travel reimbursement due to COVID-19 should be directed Alyssa Totoraitis, Regional Travel Manager, at amahn@uwsa.edu or 414-882-0995.

Frequently Asked Questions

Research Management and Development Related to COVID-19

I would like to conduct research relating to COVID-19. What should I do?

Check federal agencies for funding opportunities related to COVID-19. Then start the conversation with your dean’s office administrators to ensure you are considering various aspects of this type of research.

My research involves emerging pathogens, plasma, viruses, etc. relating to COVID-19. What should I do?

Contact the UWM Biological Safety Program if your work involves biological samples that may contain the virus (uwm-biosafety@uwm.edu, 414-588-4261) Contact the IRB if you want to do research with human subjects or biological samples that come from human subjects (irbinfo@uwm.edu, 414-229-7455). Contact the UWM Animal Care Program if you work involves animals models (berri@uwm.edu, 414-229-6016).

What should I consider when assessing how COVID-19 might affect my research?

Now is a good time to consider how an outbreak of COVID-19 in Wisconsin might affect your research. Here is a list of questions to get you started.

Here are a few simple scenarios in order to consider these impacts:

  • What would the impact be to your research and sponsored programs if you had to self-quarantine for two weeks?
  • What would the impact be to your research and sponsored programs if more than one of your research staff had to self-quarantine for two weeks?
  • What would the impact be to your research and sponsored programs if UWM advised all faculty and staff to work remotely?

Here are additional questions to help you assess how an outbreak may affect your research:

  • Are there any studies involving participants, animals, ingredients, or experiments that would be adversely affected? If so, what plans should be put in place to allow for them to continue or allow for them to be stopped and later resumed in the least impactful way?
  • What standing purchase orders or human resource issues might be impacted?
  • Would data collection/analysis/storage be impacted and what costs would be associated with these impacts?
  • What regulatory approvals will expire soon and might be impacted if they are not renewed? Can they be renewed early?
  • Are there any collaborators that would need to be notified?
  • What sponsor reports or deadlines are due during the next several months? Might you need to request a no-cost extension?
  • What notice might you need to give sponsors or regulators if the research is going to be paused or significantly delayed beyond a couple of weeks?

Additional considerations for human subjects research:

  • Is the location of the study remaining open and available for participants to be present? Has the location implemented any procedures to slow the spread of the coronavirus that will affect participation in your study or the ability of your study to proceed?
  • Does your protocol require in-person participation or treatment? Can it be modified for remote participation?
  • Does your protocol require in-person monitoring? Can it be modified for remote monitoring?
  • Should your participants be screened for coronavirus as part of your inclusion/exclusion criteria?
  • Would your data or results be affected if your participants had to self-quarantine or if they contracted coronavirus?

Additional considerations for environmental health and safety:

  • Do you have a limited number of critical lab staff with unique knowledge? Are there others in your lab who can be cross-trained?
  • Does your lab operate machines that use active cooling through liquid gasses, dry boxes, or inert boxes using gas blankets? What would happen if materials like liquid gasses, CO2, nitrogen, or dry ice become unavailable?
  • How frequently are you saving or freezing samples of your cell cultures?
  • Do you have long-term experiments that might benefit from more frequent preservation?
  • Do you have the requisite local knowledge to do controlled shutdowns of complex machines or devices without on-site help from the company?
  • Have you shared with the UWM Safety and Assurances Department the locations and amounts of materials that are air, water, or otherwise unstable for observation in case of lab closure?

Allowability of Costs Related to COVID-19

Am I allowed to pay staff who may be quarantined on sponsored funding?

Federal agencies are working internally on a number of proposal and award-related issues pertaining to COVID-19. We awaiting further communication from our partners about these issues and will provide guidance as further information becomes available. In the meantime, please continue to follow all relevant policies and procedures and apply those practices consistently. Currently, salary should be charged in a consistent manner. If an employee’s salary is charged to a sponsored program, then their time spent in quarantine can also be charged to the sponsored program.

Are travel costs, which have been canceled due to COVID-19, allowable on sponsored funding?

Federal agencies are working internally on a number of proposal and award-related issues pertaining to COVID-19. We are awaiting further communication from our partners about these issues and will provide guidance as further information becomes available. In the meantime, please continue to follow all relevant policies and procedures and apply those practices consistently. Currently, per UW travel guidelines, as long as the circumstances were outside of the traveler’s control, fees for changing/canceling flights are payable/reimbursable by the University (e.g. meeting dates changed). If the original expense was allocable to a sponsored project, the subsequent fees for changing/canceling Check here for updates regarding how COVID-19 is affecting sponsored programs at UWM. If you have any information to share, please e-mail us at grant-notice@uwm.edu.

Resources

Title Description
American Heart Association (AHA) Notice to AHA Research Community Regarding COVID-19
BBRF Deadline Extension The Brain & Behavior Research Foundation is extending the deadline for the 2020 BBRF Young Investigator Grant to March 31, 2020.
CDC Interim Guidance for IHE Administrators This interim guidance from the U.S. Centers for Disease Control and Prevention, intended for institutions of higher education, is based on what is currently known about the transmission and severity of coronavirus disease 2019 (COVID-19).
DHHS (Department of Health and Human Services) (PDF) DHHS Preparation for Potential COVID-19 Impact on Contract and Contractor Performance
DOD (Department of Defense) Research Directorate FAQs for DOD Research Proposers and Awardees Impacted by the Novel Coronavirus (March 24)
DOE National Lab Updates Guidance related to risks of COVID-19 spread from Battelle (PDF). Similar communication from Brookhaven National Lab (PDF).
DOE Office of Science (PDF) Guidance on travel (PDF) and accommodating interruptions from Coronavirus Disease 2019 (COVID-19).
DOE Seeking Input and Collaboration on S&T Response to COVID-19 (PDF) DOE is seeking ideas about how DOE and the National Labs might contribute resources to help address COVID-19 through science and technology efforts and collaborations.
DOJ COPS Office The DOJ Office of Community Oriented Policing Services has extended the solicitation deadline for several open grant programs due to the potential impact of jurisdictional emergency responses to COVID-19 that may cause reasonable delays for applicants. For detailed individual program information, see the grants page.
DOJ Implementation of OMB Memorandum M-20-17 (PDF) Department of Justice’s implementation of OMB Memorandum M-20-17 “Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations” dated March 19, 2020.
DOJ OJP Update (PDF) An update for grantees from the Office of Justice Programs at the Department of Justice.
Food and Drug Administration (FDA) Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 (March 27).
Health Resources & Services Administration (HRSA) FAQs for Grantees
Institutional and Agency Responses to COVID-19 and Additional Resources A collection of resources from various institutions of higher education compiled by the Council On Governmental Relations.
Institute of Museum and Library Services (IMLS) New Application Deadline Changes and other updates.
John Templeton Foundation A Message to Our Grantees on COVID-19 (March 23)
Mellon Foundation Message The Mellon Foundation’s communication regarding work interruptions due to COVID-19.
NASA Coronavirus Information Updates and resources regarding COVID-19 from NASA.
NASA Update for Researchers NASA Update for Research Virtual Town Hall 2020 (March 23)
NEA FAQs National Endowment for the Arts FAQs for Applicants & Awardees in Response to COVID-19
NIH COVID-19 FAQs NIH FAQs on Proposal Submission and Award Management Related to COVID-19 (Issued March 10)
NIH Extramural Nexus Special COVID-19 Edition of the NIH Extramural Nexus. Click here to subscribe to the newsletter, which provides regular updates on NIH grants policies and activities that impact the entire grants community. In addition to providing the community with news, events and resources, the Nexus is the home of Open Mike — the blog of Dr. Michael Lauer, who serves as NIH’s Deputy Director for Extramural Research and directs the Office of Extramural Research.
NIH Guide Notice 20-086 Flexibilities available to applicants and recipients of federal financial assistance affected by COVID-19.
NIH COVID-19 Resource Page NIH information including NIH guidance on travel and meetings.
NIH Extramural Response to Natural Disasters and Other Emergencies NIH policies on natural disasters and other emergencies.
NIH Late Application Policy Due to COVID-19 (March 9) NIH special provisions implemented in response to COVID-19. (Issued March 9)
NIH Notice of Early Expiration of NOSI NOT-A1-20-030 Notice of Early Expiration of NOSI NOT-AI-20-030 Regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (March 27).
NIH Update; Late Application Policy Due to COVID-10 NIH Late Application Policy due to Public Health Emergency for US for COVID-19 (March 26)
NSF COVID-19 FAQs Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees.
NSF Dear Colleague Letter NSF’s Dear Colleague Letter with information regarding the RAPID funding mechanism as it relates to COVID-19.
NSF Implementation of OMB Memorandum M-20-17 (PDF) NSF’s implementation of OMB Memorandum M-20-17 “Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations” dated March 19, 2020.
NSF Statement on Coronavirus Disease 2019 (COVID-19) (PDF) NSF actions in response to COVID-19. (Issued March 9)
NSF Statement on Existing Deadline Dates (PDF) National Science Foundation (NSF) Notice, March 18, 2020. Proposers are advised that NSF is extending the deadline date for certain solicitations or Dear Colleague Letters (DCLs). Additional solicitations or DCLs may be added to the list, so proposers are strongly encouraged to check NSF’s website regularly.
OLAW Disaster Planning and Response Resources The Office of Laboratory Animal Welfare (OLAW) maintains a list of resources and has a list of FAQs, click on G9 to read about how to prepare for a pandemic.
PCORI Guidance Related to Impact of COVID-19 Description: PCORI recognizes that management of COVID-19 is a rapidly evolving and dynamic situation that may impact PCORI-funded awards. If you are encountering institutional or personal challenges or have other concerns related to your PCORI award, please reach out as soon as possible to your PCORI project team: Program Officer, Program Associate, and Contract Administrator. You may also reach us at fundedpfa@pcori.org.
SAMHSA COVID-19 Information for Substance Abuse and Mental Health Services Administration (SAMHSA) Discretionary Grant Recipients
Space Telescope Science Institute (PDF) COVID-19 Impact on the James Webb Space Telescope Cycle 1 GO Proposal Deadline
Spencer Foundation Update from the Spencer Foundation on COVID-19
USDA (United States Department of Agriculture) NIFA Deadline Extensions Due to COVID-19
UWM COVID-19 Updates Up-to-date information from the University of Wisconsin-Milwaukee.
UWM Research Laboratories and Facilities and the COVID-19 Pandemic (March 18, 2020 (PDF) Guidance for working and meeting remotely and developing contingency plans for research and laboratory operations.
USAMRAA (PDF) Notice from the U.S. Army Medical Research Acquisition and CDMRP for applicants and awardees in response to COVID-19.
WHO COVID-19 information Information and guidance from the World Health Organization regarding the current outbreak of Coronavirus Disease (COVID-19).

UW System: Travel Reimbursement Due to COVID-19 (Issued March 11)

With Chancellor Mone’s recent guidance regarding travel, the following clarifies UW System policies and procedures regarding cancelled airline tickets and reimbursement due to COVID-19.

  • UW System will not be returning any expense reports that have change fees tickets due to Coronavirus.
  • Tickets cancelled due to Coronavirus are a reimbursable expense.
  • Airline Tickets can be cancelled in Concur or by contacting an agent. Typically, tickets stay clarity regarding cancelled airline tickets and reimbursement due to the Coronavirus in the ticket holder’s Concur profile for up to a year. However, due to the upcoming change in travel agencies in July, we are working with our new agency on how travelers can access unused tickets after July 1. Best practice right now is to screenshot and save record of your unused ticket for verification purposes going forward.
  • If a basic economy ticket was booked, no ticket value can be saved and the entire value of the ticket is lost. While cancelled tickets reimbursable if cancelled due to Coronavirus – no unused tickets will be in the traveler’s profile for future use.
  • Review hotel cancellation policies and cancel any hotel reservations ASAP.
  • Questions regarding travel reimbursement due to COVID-19 should be directed Alyssa Totoraitis, Regional Travel Manager, at amahn@uwsa.edu or 414-882-0995.

Frequently Asked Questions

Research Management and Development Related to COVID-19

I would like to conduct research relating to COVID-19. What should I do?

Check federal agencies for funding opportunities related to COVID-19. Then start the conversation with your dean’s office administrators to ensure you are considering various aspects of this type of research.

My research involves emerging pathogens, plasma, viruses, etc. relating to COVID-19. What should I do?

Contact the UWM Biological Safety Program if your work involves biological samples that may contain the virus (uwm-biosafety@uwm.edu, 414-588-4261) Contact the IRB if you want to do research with human subjects or biological samples that come from human subjects (irbinfo@uwm.edu, 414-229-7455). Contact the UWM Animal Care Program if you work involves animals models (berri@uwm.edu, 414-229-6016).

What should I consider when assessing how COVID-19 might affect my research?

Now is a good time to consider how an outbreak of COVID-19 in Wisconsin might affect your research. Here is a list of questions to get you started.

Here are a few simple scenarios in order to consider these impacts:

  • What would the impact be to your research and sponsored programs if you had to self-quarantine for two weeks?
  • What would the impact be to your research and sponsored programs if more than one of your research staff had to self-quarantine for two weeks?
  • What would the impact be to your research and sponsored programs if UWM advised all faculty and staff to work remotely?

Here are additional questions to help you assess how an outbreak may affect your research:

  • Are there any studies involving participants, animals, ingredients, or experiments that would be adversely affected? If so, what plans should be put in place to allow for them to continue or allow for them to be stopped and later resumed in the least impactful way?
  • What standing purchase orders or human resource issues might be impacted?
  • Would data collection/analysis/storage be impacted and what costs would be associated with these impacts?
  • What regulatory approvals will expire soon and might be impacted if they are not renewed? Can they be renewed early?
  • Are there any collaborators that would need to be notified?
  • What sponsor reports or deadlines are due during the next several months? Might you need to request a no-cost extension?
  • What notice might you need to give sponsors or regulators if the research is going to be paused or significantly delayed beyond a couple of weeks?

Additional considerations for human subjects research:

  • Is the location of the study remaining open and available for participants to be present? Has the location implemented any procedures to slow the spread of the coronavirus that will affect participation in your study or the ability of your study to proceed?
  • Does your protocol require in-person participation or treatment? Can it be modified for remote participation?
  • Does your protocol require in-person monitoring? Can it be modified for remote monitoring?
  • Should your participants be screened for coronavirus as part of your inclusion/exclusion criteria?
  • Would your data or results be affected if your participants had to self-quarantine or if they contracted coronavirus?

Additional considerations for environmental health and safety:

  • Do you have a limited number of critical lab staff with unique knowledge? Are there others in your lab who can be cross-trained?
  • Does your lab operate machines that use active cooling through liquid gasses, dry boxes, or inert boxes using gas blankets? What would happen if materials like liquid gasses, CO2, nitrogen, or dry ice become unavailable?
  • How frequently are you saving or freezing samples of your cell cultures?
  • Do you have long-term experiments that might benefit from more frequent preservation?
  • Do you have the requisite local knowledge to do controlled shutdowns of complex machines or devices without on-site help from the company?
  • Have you shared with the UWM Safety and Assurances Department the locations and amounts of materials that are air, water, or otherwise unstable for observation in case of lab closure?

Allowability of Costs Related to COVID-19

Am I allowed to pay staff who may be quarantined on sponsored funding?

Federal agencies are working internally on a number of proposal and award-related issues pertaining to COVID-19. We awaiting further communication from our partners about these issues and will provide guidance as further information becomes available. In the meantime, please continue to follow all relevant policies and procedures and apply those practices consistently. Currently, salary should be charged in a consistent manner. If an employee’s salary is charged to a sponsored program, then their time spent in quarantine can also be charged to the sponsored program.

Are travel costs, which have been canceled due to COVID-19, allowable on sponsored funding?

Federal agencies are working internally on a number of proposal and award-related issues pertaining to COVID-19. We are awaiting further communication from our partners about these issues and will provide guidance as further information becomes available. In the meantime, please continue to follow all relevant policies and procedures and apply those practices consistently. Currently, per UW travel guidelines, as long as the circumstances were outside of the traveler’s control, fees for changing/canceling flights are payable/reimbursable by the University (e.g. meeting dates changed). If the original expense was allocable to a sponsored project, the subsequent fees for changing/canceling travel would also be allocable to that project.travel would also be allocable to that project.